AFP evaluation is useful: a) for screening and diagnosis of HCC in patients at risk of developing HCC, in association to hepatic ultrasonography; (b) during staging within CLIP (Cancer of the liver Italian program) staging system; (c) as a marker for detecting tumor progression in patients with AFP-producing HCC. The gene discussed is AFP; the disease is neoplasm.